New Atlas

Extraordinary ideas that move the world forward

FDA approves clinical trial of cold plasma "scalpel" for cancer treatment
2019-08-20 07:09 UTC by Michael Irving

Cancer is a crafty foe, not least because traces often remain after surgery and can trigger a relapse later on. Now a new technology to fight those dangerous leftovers – a cold atmospheric plasma system – has been approved for human clinical trials by the US Food and Drug Administration (FDA).

• Cancer
• FDA
• Plasma
• Purdue University
• Surgery
• Tumor

Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative.